Quantification of plasma hTERT DNA in hepatocellular carcinoma patients by quantitative fluorescent polymerase chain reaction

Clinical and Investigative Medicine

Volumn 34, Issue 4, 2011, Pages

  Yang, Ying Jun ^a   Chen, Hui ^a   Huang, Ping ^a   Li, Cheng Hua ^a   Dong, Zi He ^a   Hou, Yu Lei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE; TERT PROTEIN, HUMAN;

ARTICLE; BLOOD; FEMALE; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METHODOLOGY; MIDDLE AGED; POLYMERASE CHAIN REACTION;

CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TELOMERASE;

EID: 80051804456     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Elenitoba-Johnson KSJ. Complex regulation of telomerase activ ity. Am J Pathol 2001; 159: 405-410.
2. Tahara H, NakaniShi T, Kitamoto M, Nakashio R, Shay JW, Tahara E, Kajiyama G, Ide T. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995; 55: 2734-2736.
3. Horikawa I, Carl Barrett J. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 2003; 24: 1167-1176.
4. Zhang A, Zheng C, Lindvall C, Hou M, Ekedahl J, Lewensohn R, Yan Z, Yang X, Henriksson M, Blennow E, Nordenskjold M, Zetterberg A, Bjorkholm M, Gruber A, Xu D. Frequent amplification of the telomerase reverse transcriptase gene in human tumors. Cancer Res 2000; 60: 6230-6235.
5. Zhang A, Zheng C, Hou M, Lindvall C, Wallin KL, Angstrom T, Yang XY, Hellstrom AC, Blennow E, Bjorkholm M, Zetter berg A, Xu D. Amplification of the telomerase reverse transcrip tase (hTERT) gene in cervical carcinomas. Gene Chromosome Canc 2002; 34: 269-275.
6. Fan X, Wang Y, Kratz J, Brat DJ, Robitaille Y, Moghrabi A, Perlman EJ, Dang CV, Burger PC, Eberhart CG. hTERT gene amplification and increased mRNA expression in central nerv ous system embryonal tumors. Am J Pathol 2003; 162: 17631769.
7. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL, Shay JW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015.
8. Shay JW, Bacchetti S. A survey of telomerase activity in hu man cancer. Eur J Cancer 1997; 33: 787-791.
9. Max Parkin D, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49: 33-64.
10. Leng T, Liu N, Chen X. Dissection of DEN-induced platelet proteome changes reveals the progressively dys-regulated path ways indicative of hepatocarcinogenesis. J Proteome Res, 2010;9:6207-6219.
11. Maheshwari A, Kantsevoy S, Jagannath S, Thuluvath PJ. Endoscopic ultrasound and fine-needle aspiration for the diagnosis of hepatocellular carcinoma. Clin Liver Dis 2010; 14: 325-332.
12. Debruyne EN, Delanghe JR. Diagnosing and monitoring hepa tocellular carcinoma with alpha-fetoprotein: New aspects and applications. Clin Chim Acta 2008; 395: 19-26.
13. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977; 37:646-650.
14. Goebel G, Zitt Mar, Zitt Mat, Müller HM. Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias. Dis Markers 2005; 21: 105-120.
15. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer - A survey. Biochim Biophys Acta 2007; 1775: 181232.
16. Dobrzycka B, Terlikowski SJ, Mazurek A, Kowalczuk O, Niklinska W, Chyczewski L, Kulikowski M. Circulating free DNA, p53 antibody and mutations of K-ras gene in endometrial cancer. Int J Cancer 2010; 127: 612-621.
17. Lofton-Day C, Model F, DeVos T, Tetzner R, Distler J, Schuster M, Song X, Lesche R, Liebenberg V, Ebert M, Molnar B, Grützmann R, Pilarsky C, Sledziewski A. DNA Methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 2008; 54: 414-423.
18. Nakamoto D, Yamamoto N, Takagi R, Katakura A, Mizoe JE, Shibahara T. Detection of micro satellite alterations in plasma DNA of malignant mucosal melanoma using genome amplification. Bull Tokyo Dent Coll 2008; 49: 77-87.
19. Ginzinger DG. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 2002; 30: 503-512.
20. Sozzi G, Conte D, Leon M, Cirincione R, Luca R, Ratclif Fe, Roz E, Cirenei N, Bellomi M, Pelosi G, Pierotti MA, Pastorino U. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003; 21: 3902-3908.
21. Catarino R, Ferreira MM, Rodrigues H, Coelho A, Nogal A, Sousa A, Medeiros R. Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer. DNA Cell Biol 2008; 27: 415-421.
22. Miura N, Maeda Y, Kanbe T, Yazama H, Takeda Y, Sato R, Tsukamoto T, Sato E, Marumoto A, Harada T, Sano A, Kishimoto Y, Hirooka Y, Murawaki Y, Hasegawa J, Shiota G. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma. Clin Cancer Res 2005;11: 3205-3209.
23. Danese E, Montagnana M, Minicozzi AM, De Matteis G, Scudo G, Salvagno GL, Cordiano C, Lippi G, Guidi GC. Real-time polymerase chain reaction quantification of free DNA in serum of patients with polyps and colorectal cancers. Clin Chem Lab Med 2010; 48: 1665-1668.
24. Schwarzenbach H, Alix-Panabières C, Müller L, Letang N, Vendrell JP, Rebillard X, Pantel K. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer. Clin Cancer Res 2009; 15: 1032-1038.
25. Paci M, Maramotti S, Bellesia E, Formisano D, Albertazzi L, Ricchetti T, Ferrari G, Annessi V, Lasagni D, Carbonelli C, Franco SD, Brini M, Sgarbi G, Lodi R. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer. Lung Cancer 2009; 64: 92-97.
26. Ellinger J, Wittkamp V, Albers P, Perabo FGE, Mueller SC, Ruecker AV, Bastian PJ. Cell-Free circulating DNA: diagnostic value in patients with testicular germ cell cancer. J Urol 2009; 181: 363-371.
27. Zhong XY, Ladewig A, Schmid S, Wight E, Hahn S, Holzgreve W. Elevated level of cell-free plasma DNA is associated with breast cancer. Arch Gynecol Obstet 2007; 276: 327-331.
28. Sai S, Ichikawa D, Tomita H, Ikoma D, Tani N, Ikoma H, Kikuchi S, Fujiwara H, Ueda Y, Otsuji E. Quantification of plasma cell-free DNA in patients with gastric cancer. Anticancer Res 2007; 27: 2747-2752.
29. Lee TH, Montalvo L, Chrebtow V. Busch MP. Quantitation of genomic DNA in plasma and serum samples: higher concentra tions of genomic DNA found in serum than in plasma. Transfusion 2001; 41: 276-282.
30. Allen Chan KC, Yeung SW, Lui WB, Rainer TH, Dennis Lo YM. Effects of preanalytical factors on the molecular size of cellfree DNA in blood. Clin Chem 2005; 51: 781-784.
31. Board RE, Williams VS, Knight L, Shaw J, Greystoke A, Ranson M, Dive C, Blackhall FH, Hughes A. Isolation and extraction of circulating tumor DNA from patients with small cell lung cancer. Ann NY Acad Sci 2008; 1137: 98-100.
32. Chiu RWK, Poon LLM, Lau TK, Leung TN, Wong EMC, Dennis Lo YM. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 2001; 47: 1607-1613.
33. Divella R, Tommasi S, Lacalamita R, Daniele A, Abbate I, Michele V, Savino E, Coviello M, Rubini V, Simone G, Paradiso A, Quaranta M. Circulating h TERT DNA in early breast cancer. Anticancer Res 2009; 29: 2845-2850.
34. Sirera R, Bremnes RM, Cabrera A, Jantus-Lewintre E, Sanmartín E, Blasco A, Del Pozo N, Rosell R, Guijarro R, Galbis J, Sanchez JJ, Camps C. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer. J Thorac Oncol 2011; 6: 286-290.
35. Altimari A, Grigioni AD, Benedettini E, Gabusi E, Schiavina R, Martinelli A, Morselli-Labate AM, Martorana G, Grigioni WF, Fiorentino M. Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer. Am J Clin Pathol 2008; 129: 756-762.
36. Sozzi G, Conte D, Mariani L, Vullo SL, Roz L, Lombardo C, Pierotti MA, Tavecchio L. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 2001; 61: 4675-4678.
37. Flamini E, Mercatali L, Nanni O, Calistri D, Nunziatini R, Zoli W, Rosetti P, Gardini N, Lattuneddu A, Verdecchia GM, Amadori D. Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer. Clin Cancer Res 2006; 12: 6985-6988.
38. Miura N, Nakamura H, Sato R, Tsukamoto T, Harada T, Takahashi S, Adachi Y, Shomori K, Sano A, Kishimoto Y, Ito H, Hasegawa J, Shiota G. Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer. Cancer Sci 2006; 97: 1366-1373.
39. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011; 11: 426437.